PRADAXA is the first approved oral alternative to warfarin in over 50 years to reduce the risk of stroke in patients with AFib not caused by a heart valve problem. PRADAXA is not for use in people with artificial heart valves.

The American Association for Thoracic Surgery, in cooperation with Mount Sinai Medical Center and Westchester Medical Center, will hold a 2-day symposium focused on the pathophysiology, diagnosis and treatment of aortic aneurysms and dissections.